US Stock Market Move | The new futures and derivatives trading platform will be launched next year, Robinhood (HOOD.US) rose over 6.5%.
As of the time of the article, the stock has risen more than 6.5% to $123.17.
On Wednesday, Robinhood (HOOD.US) stock price surged, rising over 6.5% to $123.17 as of the time of writing. On the news front, Robinhood is launching a futures and derivatives exchange and clearinghouse to deepen its investment in the prediction market. By partnering with Susquehanna, a market maker, to establish a new independent joint venture, Robinhood will act as the controlling partner and provide retail demand and distribution channels. Susquehanna International Group will be a key partner and initial liquidity provider on the first day, with plans to introduce other liquidity providers in the future. The joint venture will accelerate its service delivery through the acquisition of MIAXdx.
MIAXdx is a designated contract market (DCM), derivatives clearing organization (DCO), and swap execution facility (SEF) licensed by the Commodity Futures Trading Commission (CFTC), and a wholly-owned subsidiary of Miami International Holdings (MIAX.US). MIAX will continue to maintain a strategic 10% ownership in the exchange. This independent joint venture will provide futures and derivative products for futures commission merchants (FCMs), including the Robinhood prediction market, which is expected to start operating in 2026.
Related Articles

A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

DOWWAY (08403) received an acquisition of controlling stake by Sun Wei and a discount of about 65.75% in cash tender offer. It will resume trading on November 27th.
A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

DOWWAY (08403) received an acquisition of controlling stake by Sun Wei and a discount of about 65.75% in cash tender offer. It will resume trading on November 27th.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


